Faron Pharmaceuticals Limited (AIM:FARN), the clinical-stage immunotherapy company, has terminated its liquidity provision agreement with Lago Kapital Oy, with effect from 5 June. The Finnish company said it considers its share liquidity sufficient without additional support.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com